Continuous Spinal Anesthesia in Renal Transplantation

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 20, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Renal Failure ChronicTransplant;Failure,KidneyAnesthesia
Interventions
PROCEDURE

Continuous spinal anesthesia

Continuous spinal anesthesia will be performed for patients of the CSA group at the L3-L4 intervertebral space using Spinocath (B. Braun, Melsungen, Germany). After the cerebrospinal fluid is aspirated, 7.5 mg hyperbaric Bupivacaine 0.5% (1.5 ml) together with 25 micrograms Fentanyl (0.5 ml) will be injected intra-thecally. Supplemental injections will be given in aliquots of 5 mg hyperbaric Bupivacaine 0.5% (1 ml) if the sensory block is lower or reseeds, during surgery, below T6 dermatome.

PROCEDURE

General anesthesia

Anesthesia will be induced with intra-venous administration of Fentanyl (2 micrograms/kg), Ptopofol (1-2 mg/kg) and Atracurium (0.5 mg/kg). Maintenance will be achieved with 0.8-1.5% Isoflurane in an O2 / air mixture, an Atracurium infusion at 0.5 mg/kg/hr and a Fentanyl infusion at 1 micrograms/kg/hr.

Trial Locations (1)

Unknown

Kasr Al-Ainy Hospital, Cairo University, Cairo

All Listed Sponsors
lead

Nazmy Edward Seif

OTHER

NCT03436368 - Continuous Spinal Anesthesia in Renal Transplantation | Biotech Hunter | Biotech Hunter